Faeth Therapeutics, Inc. (FTH)
Market Open
17 Jul, 17:19
NASDAQ (CM) NASDAQ (CM) Primary $
25. 77
-0.17
-0.6554%
$
44.45M Market Cap
- P/E Ratio
- Div Yield
70,926 Volume
- Eps
$ 25.94
Previous Close 
Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faeth Therapeutics, Inc. (FTH) Statistics
Valuation metrics
Market Cap 44.45M
Enterprise value -102.76M
Trailing P/E (ttm) -0.24
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -10
Price/Book (mrq) 0.24
Enterprise Value/Revenue 21.18
Enterprise Value/EBITDA 0.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 237.74K
Average volume (90 days) 54.57K
Price summary
52-Week low 6.33
52-Week high 37.9
Beta -
50-Day moving average 17.26
200-Day moving average 21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 17 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 38.02%
Operating margin 38.27%
Operational effectiveness
Return on assets -0.9%
Return on equity -2.84%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -3.75
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -142.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 156.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 14.39%
Book value per share (mrq) 147.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
